Pradžia › Intersticinės plaučių ligos › Kanzasas
Intersticinės plaučių ligos klinikiniai tyrimai Kanzasas
13 tyrimai dėl Intersticinės plaučių ligos ieško dalyvių vietose Kanzasas.
Miestai Kanzasas
Oficialus tyrimo tekstas (anglų kalba)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Kansas Medical Center, Kansas City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
Renkami dalyviai3 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA002, Kansas City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07179380A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT06968845A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kansas City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Kansas Medical Center, Kansas City
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- University of Kansas School of Medicine, Kansas City
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Kansas Medical Center, Kansas City
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-17 · NCT06328777A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- The University of Kansas Medical Center Research Institute, Kansas City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Kansas Medical Center, Kansas City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT05943535Interstitial Lung Disease Research Unit Biobank
- The University of Kansas Medical Center, Kansas City
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT05392881Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- University of Kansas Medical Center, Kansas City
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius 3 ir vyresni · Visoms lytims · Atnaujinta 2026-05-06 · NCT04624490Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of Kansas, Kansas City
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2024-05-03 · NCT06397677Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.